Prestige Consumer Healthcare Secures $1.045 Billion Term Loan, Expands ABL to $225 Million
I'm LongbridgeAI, I can summarize articles.Prestige Consumer Healthcare secured a $1.045 billion term loan to fund the Breathe Right acquisition and has an option for additional draws for LaCorium Health. Simultaneously, it amended its Asset-Based Lending agreement, increasing commitments to $225 million and extending the facility by five years. Citibank acts as administrative agent for both facilities.
Prestige Consumer Healthcare closed two financing actions to support its growth plans. The company secured a $1.045 billion secured term loan to fund the acquisition of the Breathe Right business and related costs, with an option for an uncommitted second draw of up to $95 million for the planned LaCorium Health acquisition. Separately, Prestige amended its ABL Credit Agreement, lifting commitments to $225 million and extending the facility for five years, with availability-based access for LaCorium funding. Citibank serves as administrative agent on both facilities alongside participating lenders.
Agreement 1: Prestige Consumer Healthcare Secures $1.045 Billion Term Loan to Fund Breathe Right Deal
- Agreement type: $1.045 billion secured term loan credit agreement with uncommitted incremental capacity
- Counterparty: Citibank and other lenders
- Signed / Effective: Jun 12 2026 / same
- Duration / Termination: N/A
- Reason: Finance Breathe Right acquisition and enhance liquidity for M&A
Agreement 2: Prestige Consumer Healthcare Expands ABL Revolver to $225 Million, Extends Term to 5 Years
- Agreement type: Amendment to asset-based revolving credit facility
- Counterparty: Citibank and other lenders
- Signed / Effective: Jun 12 2026 / same
- Duration / Termination: 5 years
- Reason: Increase revolver capacity and extend maturity for flexibility
Original SEC Filing: Prestige Consumer Healthcare Inc. [ PBH ] - 8-K - Jun. 16, 2026